European equities have attracted renewed investor attention amid attractive valuations relative to U.S. markets, elevated dividend yields, and a broadening earnings cycle. IEUR and SPEU compete directly as low-cost, diversified vehicles for developed European equity exposure. Both are passive, market-capitalization-weighted funds spanning large-, mid-, and small-capitalization companies. Yet they diverge in index methodology, breadth of holdings, and expense structure, making this a meaningful ETF comparison for investors weighing relative positioning and long-term cost efficiency. From what I see, the choice often comes down to small differences that add up over time.
The iShares Core MSCI Europe ETF (IEUR) seeks to track the MSCI Europe Investable Market Index (IMI), a free-float-adjusted, market-capitalization-weighted benchmark covering large-, mid-, and small-cap equities across 15 developed European markets, including the United Kingdom, France, Switzerland, and Germany. The fund employs an optimized sampling replication strategy and holds approximately 1,000 securities. Top holdings include ASML, HSBC, Roche, Novartis, Shell, AstraZeneca, Nestlé, Siemens, and SAP. Sector allocation is led by financials (roughly 23%), industrials (about 20%), and health care (around 13%), with information technology near 9%. The fund carries a net expense ratio of about 0.10% and, with roughly $9 billion in assets, offers strong liquidity and tight bid-ask spreads for institutional and retail traders alike. I also checked this using Tickeron’s AI Screener to see how the holdings align with broader industry trends.
The SPDR Portfolio Europe ETF (SPEU) seeks to correspond, before fees and expenses, to the total return performance of the STOXX Europe Total Market Index, a free-float market-capitalization-weighted benchmark designed to broadly represent publicly traded Western European companies. The fund employs a sampling strategy and holds roughly 1,700 securities, providing one of the broadest single-ticker European equity exposures available. Its top holdings mirror IEUR closely—ASML, Roche, HSBC, Novartis, Shell, AstraZeneca, Nestlé, SAP, and Siemens—with sector weightings nearly identical: financials near 23%, industrials about 20%, and health care around 13%. The fund's defining feature is cost, with a net expense ratio of just 0.07%. Assets total roughly $700 million, giving SPEU a more moderate liquidity profile than its larger peer.
Both funds are shaped by the same European macro and sector environment. European equities have traded at a persistent valuation discount to U.S. benchmarks, supported by historically low price-to-earnings multiples and above-average dividend yields. Banking and financials, the largest sector exposure in both funds, have benefited from higher interest rates and resilient net interest income. Industrials and health care—including weight-loss drugmakers and semiconductor-equipment suppliers—have provided additional earnings catalysts. Key risks include currency exposure to the euro and British pound, sensitivity to global trade dynamics, and Europe's comparatively lower allocation to high-growth technology names. Energy price swings and geopolitical developments also influence the materials and energy components of both portfolios.
Because IEUR and SPEU hold essentially the same basket of companies with near-identical sector and country weightings, their fund performance has tracked closely across recent market cycles. Both have participated in the rotation toward value-oriented and dividend-paying European equities over recent weeks and months, with financials and industrials acting as primary drivers. The practical differences lie in structure rather than return. SPEU offers slightly broader small-cap coverage through its total-market index, while IEUR provides deeper liquidity for larger trades. Volatility profiles are comparable, reflecting shared exposure to European currency and equity market risk.
In my view, tools that scan across many securities can help clarify these nuances without manual effort. Tickeron’s AI Screener lets me quickly compare expense ratios, holding counts, and liquidity metrics side by side, which is useful when deciding between similar funds like these two.
Between these two structurally similar funds, Tickeron's AI would currently favor SPEU. The reasoning rests on durable, observable factors: a lower expense ratio (0.07% versus 0.10%), broader market coverage through roughly 1,700 holdings, and essentially identical sector and country exposure to IEUR. Over long investment horizons, the fee differential and wider diversification tend to compound into a modest structural advantage. While IEUR retains superior liquidity and scale, SPEU offers the more cost-efficient and broadly diversified path for buy-and-hold investors seeking European equity exposure.
I find that incorporating AI-driven screeners into the process helps surface cost and breadth differences efficiently. Tickeron’s AI Screener has become a regular part of how I evaluate ETF options like these, letting me filter by fees, holdings, and liquidity in one place before making allocation decisions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
IEUR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 17, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In 42 of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 84%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IEUR as a result. In 70 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
IEUR moved below its 50-day moving average on November 17, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IEUR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The RSI Indicator entered the oversold zone -- be on the watch for IEUR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for IEUR crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +1.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where IEUR advanced for three days, in 258 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
IEUR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 259 of 315 cases where IEUR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows